LESLIE A HASS

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health TWIN FALLS, ID NPI 1275913824

General Payments — all program years on this page

$1,338.99

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 43
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $445.17 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $445.1718

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $133.266
E.R. Squibb & Sons, L.L.C. $132.932
ITI, Inc. $81.274
Otsuka America Pharmaceutical, Inc. $50.343
GlaxoSmithKline, LLC. $17.991
ACADIA Pharmaceuticals Inc $16.111
Amgen Inc. $13.271

By program year

Program yearAmountRecords
2021 $113.837
2022 $249.354
2023 $530.6414
2024 $445.1718

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1101852857 E.R. Squibb & Sons, L.L.C. $14.49 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101852868 E.R. Squibb & Sons, L.L.C. $118.44 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107302972 ABBVIE INC. $29.25 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107302974 ABBVIE INC. $27.92 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107302976 ABBVIE INC. $30.78 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107302978 ABBVIE INC. $23.45 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107302980 ABBVIE INC. $9.73 07/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107302982 ABBVIE INC. $12.13 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116388768 GlaxoSmithKline, LLC. $17.99 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117273399 Amgen Inc. $13.27 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119090338 Otsuka America Pharmaceutical, Inc. $18.67 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119090340 Otsuka America Pharmaceutical, Inc. $15.38 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119090342 Otsuka America Pharmaceutical, Inc. $16.29 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143485169 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.89 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143485174 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.47 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143485180 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.34 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143485186 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $17.57 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148005044 ACADIA Pharmaceuticals Inc $16.11 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.